AVTX Competitors & Alternatives
Compare Avalo Therapeutics Inc with similar stocks in the same industry
Biotechnology
AVTX
Main Stock$7.76
Tradestie Score
54
Market Cap
$170.45M
Revenue Growth
-0.7%
Analyst Upside
+348.5%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
XOMA
XOMA Royalty Corporation Common Stock
|
$40.17
|
$474.20M | 28.2 | 46 | Compare |
|
ABSI
Absci Corporation Common Stock
|
$8.45
|
$468.01M | - | 46 | Compare |
|
GLUE
Monte Rosa Therapeutics, Inc. Common Stock
|
$9.37
|
$463.20M | - | 39 | Compare |
|
SLDB
Solid Biosciences Inc. Common Stock
|
$6.84
|
$457.09M | - | 37 | Compare |
|
MRVI
Maravai LifeSciences Holdings, Inc. Class A Common Stock
|
$7.54
|
$454.29M | - | 50 | Compare |
|
RAPT
RAPT Therapeutics, Inc. Common Stock
|
$58.02
|
$450.49M | - | 50 | Compare |
|
MLTX
MoonLake Immunotherapeutics Class A Ordinary Shares
|
$12.50
|
$448.32M | - | 32 | Compare |
|
ATXS
Astria Therapeutics, Inc. Common Stock
|
$12.58
|
$425.52M | - | 54 | Compare |
|
ALMS
Alumis Inc. Common Stock
|
$5.60
|
$422.50M | - | 43 | Compare |
|
FDMT
4D Molecular Therapeutics, Inc. Common Stock
|
$12.23
|
$407.71M | - | 53 | Compare |
More AVTX Analysis
Data updated: Nov 15, 2026 | Industry: Biotechnology (SIC 2834)
220 stocks in this industry